Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 591 | 573 | 442 | 402 | 345 |
| Operating Income | -591 | -573 | -442 | -402 | -345 |
| Interest Expense | 100 | 93 | 208 | 60 | 166 |
| Other Income | -536 | 0 | 0 | 0 | 58 |
| Pre-tax Income | -1,227 | -666 | -650 | -462 | -452 |
| Net Income Continuous | -1,227 | -666 | -650 | -462 | -452 |
| Net Income | $-1,227 | $-666 | $-650 | $-462 | $-452 |
| EPS Basic Total Ops | -1.20 | -0.80 | -0.80 | -0.40 | 57.60 |
| EPS Basic Continuous Ops | -1.34 | -0.73 | -0.71 | -0.52 | 57.75 |
| EPS Diluted Total Ops | -1.20 | -0.80 | -0.80 | -0.40 | 57.60 |
| EPS Diluted Continuous Ops | -1.34 | -0.73 | -0.71 | -0.52 | 57.75 |
| EBITDA(a) | $-507 | $-553 | $-221 | $-341 | $-269 |